Recap: Castle Biosciences Q4 Earnings

Castle Biosciences CSTL reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Castle Biosciences beat estimated earnings by 81.0%, reporting an EPS of $-0.1 versus an estimate of $-0.54.

Revenue was up $27.78 million from the same period last year.

Last quarter the company beat on EPS by $0.5 which was followed by a 8.0% increase in the share price the next day.

Here's a look at Castle Biosciences's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.76	-1.01	-0.89	-0.84
EPS Actual	-0.26	-0.70	-1.10	-0.78
Revenue Estimate	48.52M	43.51M	37.37M	37.16M
Revenue Actual	61.49M	50.14M	42.04M	38.34M

To track all earnings releases for Castle Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Overview Rating:

Speculative

100

0100

Earnings Calendar